Dr. Bruce Goldsmith
Biopharma company Lycera Corp has announced Dr. Bruce Goldsmith has been appointed to be the new Chief Business Officer.
Goldsmith comes directly from Allos Therapeutics where he served as senior vice president corporate development, and has also had roles in various strategic marketing and business development positions with the Johnson & Johnson family of companies.
Lycera’s CEO Dr. Kathleen Metters said: “He brings a proven track record of driving corporate and product strategy, leading business development efforts and creating valuable external partnerships.”